tiletamine hydrochloride has been researched along with Alloxan Diabetes in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J; Huang, J; Liu, B; Wang, R; You, T | 1 |
| Asahi, Y; Harashima, H; Kamachi, H; Koshizuka, Y; Kuraya, D; Matsushita, M; Nakamura, T; Ogura, M; Ozaki, M; Todo, S; Umezawa, K; Watanabe, M; Yamashita, K; Yoshida, T | 1 |
| Cai, L; Fang, Q; Huang, Y; Liang, G; Miao, L; Pan, Y; Peng, K; Sun, Y; Tong, C; Wang, Y; Wang, Z; Zhao, Y | 1 |
| Andreani, T; Belani, J; Bradley, P; Cao, Y; Chen, P; Cox, K; Dai, P; Dai, X; DeMong, D; Feng, KI; Gauuan, J; Greenlee, W; Grotz, D; Hwa, J; Kang, L; Kozlowski, J; Lachowicz, J; Lavey, B; Liang, M; Lin, P; Lin, SI; McNamara, P; Meng, T; Miller, M; Morrison, R; Patel, B; Sondey, C; Soriano, A; Stamford, A; Wong, J; Wong, M; Yang, DY; Yu, W; Zhai, Y; Zhang, H; Zhao, H; Zhou, G | 1 |
| Belmadani, S; Choi, SK; Galán, M; Kassan, M; Matrougui, K; Trebak, M | 1 |
| Cai, L; Liang, G; Liu, Q; McClung, K; Pan, Y; Sun, J; Sun, W; Tan, Y; Wang, Y; Zhao, Y; Zhou, S | 1 |
| Cai, L; Cai, Y; Feng, Z; Hu, J; Li, J; Li, X; Liang, G; Pan, Y; Wang, Y; Yang, S; Yu, C | 1 |
| Kinoshita, Y; Kono, T; Saito, M; Satoh, I; Satoh, K; Shomori, K; Suzuki, H; Yamada, M | 1 |
| Koyama, K; Monden, M; Shiomi, H; Suzuki, H; Tamura, Y; Yamada, M | 1 |
| Inoue, M; Ishida, S; Izumi-Nagai, K; Koto, T; Nagai, N; Oike, Y; Ozawa, Y; Satofuka, S; Tsubota, K; Umezawa, K; Yamashiro, K | 1 |
| Kazuyama, E; Okada, S; Saito, M; Satoh, K | 1 |
| Mitani, H; Saito, M; Satoh, K; Shinbori, C; Shirayama, Y | 1 |
| Mannering, GJ; Shoeman, DW; Shoeman, JA | 1 |
13 other study(ies) available for tiletamine hydrochloride and Alloxan Diabetes
| Article | Year |
|---|---|
A Synthetic Curcuminoid Analog, (2
Topics: Animals; Benzylidene Compounds; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diarylheptanoids; Male; Mice; MicroRNAs; Wound Healing | 2020 |
Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: I. HMGB1 suppression by DHMEQ prevents early islet graft damage.
Topics: Animals; Benzamides; Cyclohexanones; Diabetes Mellitus, Experimental; HMGB1 Protein; Islets of Langerhans Transplantation; Liposomes; Macrophage Activation; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Postoperative Complications; Streptozocin | 2013 |
Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy.
Topics: Angiotensin II; Animals; Benzylidene Compounds; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Hyperglycemia; Kidney; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Protein Kinase Inhibitors; Renin-Angiotensin System; Signal Transduction; Streptozocin | 2014 |
The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist.
Topics: Animals; Benzamides; Blood Glucose; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Drug Discovery; Glucagon; Mice; Mice, Inbred ICR; Obesity; Prediabetic State; Receptors, Glucagon; Spiro Compounds; Structure-Activity Relationship | 2014 |
Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic mice.
Topics: Animals; Aorta, Thoracic; Arteries; Benzamides; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelium, Vascular; Heart Conduction System; I-kappa B Proteins; Male; Mice; Mice, Knockout; NF-kappa B; Vasodilation | 2015 |
Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression.
Topics: Animals; Apoptosis; Benzylidene Compounds; Blood Pressure; Blotting, Western; Coloring Agents; Curcumin; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Echocardiography; Endoplasmic Reticulum Stress; Fibrosis; Heart; JNK Mitogen-Activated Protein Kinases; Lipid Peroxidation; Male; Metallothionein; Mice; Mice, Inbred C57BL; Myocardium; Oxidative Stress; Phosphorylation; Protein Kinase Inhibitors; Real-Time Polymerase Chain Reaction | 2014 |
Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylidene Compounds; Blood Glucose; Blotting, Western; Body Weight; Cell Culture Techniques; Cell Movement; Curcumin; Cyclohexanones; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Fibrosis; Glucose; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Organ Size; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction | 2012 |
General administration of cyclohexenonic long-chain fatty alcohol ameliorates hyperreactivity of STZ-induced diabetic rat aorta.
Topics: Acetylcholine; Animals; Aorta; Blood Glucose; Cyclohexanones; Diabetes Mellitus, Experimental; Fatty Alcohols; In Vitro Techniques; Male; Malondialdehyde; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Reference Values; Vasoconstriction; Vasodilation | 2006 |
Beneficial action of 2,4,4-trimethyl-3-(15-hydroxypentadecyl)-2-cyclohexen-1-one, a novel long-chain fatty alcohol, on diabetic hypoalgesia and neuropathic hyperalgesia.
Topics: Analgesics; Animals; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Fatty Alcohols; Hyperalgesia; Male; Mice; Mice, Inbred Strains; Pain Threshold | 2006 |
Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzamides; Blotting, Western; Cell Adhesion; Chemokine CCL2; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Imidazoles; Intercellular Adhesion Molecule-1; Leukocytes; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Pyridines; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Retinitis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Thiazolidines; Valine; Valsartan; Vascular Endothelial Growth Factor A | 2007 |
Ability of cyclohexenonic long-chain fatty alcohol to ameliorate diabetes-induced cystopathy in the rat.
Topics: Animals; Cyclohexanones; Diabetes Mellitus, Experimental; Fatty Alcohols; Male; Rats; Rats, Sprague-Dawley; Urinary Bladder Diseases | 2008 |
Effects of cyclohexanonic long-chain fatty alcohol, tCFA15 on amino acids in diabetic rat brain: a preliminary study.
Topics: Amino Acids; Animals; Blood Glucose; Body Weight; Brain Chemistry; Chromatography, High Pressure Liquid; Cyclohexanones; Diabetes Mellitus, Experimental; Fatty Alcohols; Insulin; Male; Rats; Rats, Sprague-Dawley | 2008 |
Effects of colupulone, a component of hops and brewers yeast, and chromium on glucose tolerance and hepatic cytochrome P450 in nondiabetic and spontaneously diabetic mice.
Topics: Animals; Chromium; Cyclohexanones; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Glucose; Glycated Hemoglobin; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Saccharomyces cerevisiae | 1994 |